Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis

Autor: Tong Liu, Mengqi Gong, Konstantinos Lampropoulos, Leonardo Roever, Lorraine Lok Wing Chiang, Teddy Tai Loy Lee, George Bazoukis, Keith Sai Kit Leung, Ka Hou Christien Li, King Sum Luk, Gary Tse, Vincent Lok Cheung Yuen, Ching Ki Chan, Kevin Ho, Christina Ip

Publikováno v: International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology: Heart & Vasculature, Vol 37, Iss, Pp 100887-(2021)

Objectives: Soluble suppression of tumorigenicity 2 (sST2) is a member of the interleukin-1 receptor family. It is raised in various cardiovascular diseases, but its value in predicting disease severity or mortality outcomes has been controversial. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7108066b77e6f6c703c32a4742410fa
https://doi.org/10.1016/j.ijcha.2021.100887

Prognostic value of soluble ST2 postaortic valve replacement: a meta-analysis

Autor: Christina Ip, Tong Liu, Gary Tse, Yan Yee Ting, Ishan Lakhani, Martin C.S. Wong, Mengqi Gong, Konstantinos P. Letsas, Mei Dong, George Bazoukis, King Sum Luk, Guangping Li

Objectives Soluble suppression of tumorigenicity 2 (sST2) is a member of the interleukin-1 receptor family and a modulator of hypertrophic and fibrotic responses. Its prognostic value for patients undergoing aortic valve replacement (AVR) has been ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39f4bcb3def26e11c08302b4c42defe
https://europepmc.org/articles/PMC5890061/